{"id":182839,"date":"2026-08-04T10:56:57","date_gmt":"2026-08-04T05:26:57","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=182839"},"modified":"2026-08-04T10:56:59","modified_gmt":"2026-08-04T05:26:59","slug":"molbio-diagnostics-initial-public-offering-rhp-files","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/molbio-diagnostics-initial-public-offering-rhp-files\/","title":{"rendered":"Molbio Diagnostics IPO Files RHP: Temasek, Motilal Oswal-Backed Firm to Open Issue August 10"},"content":{"rendered":"
<\/div>\n

Molbio Diagnostics IPO opens August 10. Fresh issue Rs 200 crore. OFS 91.66 lakh shares. Goa-headquartered, backed by Temasek and Motilal Oswal.<\/em><\/p>\n

The Molbio Diagnostics IPO has moved a step closer to launch, with the Goa-headquartered diagnostics company filing its Red Herring Prospectus (RHP) ahead of the issue opening on August 10, 2026.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

Through the Molbio Diagnostics IPO, the company is raising Rs 200 crore via a fresh issue of shares, while existing shareholders will sell 91.66 lakh shares through an offer-for-sale. The issue counts Temasek and Motilal Oswal among its backers, lending institutional credibility to the offering ahead of its market debut on the exchanges.<\/p>\n\n\n\n\n\n\n\n\n\n
Detail<\/th>\nValue<\/th>\n<\/tr>\n<\/thead>\n
Fresh issue size<\/td>\nRs 200 crore<\/td>\n<\/tr>\n
Offer for sale<\/td>\n91.66 lakh shares<\/td>\n<\/tr>\n
Headquarters<\/td>\nGoa, India<\/td>\n<\/tr>\n
Key backers<\/td>\nTemasek, Motilal Oswal<\/td>\n<\/tr>\n
Subscription opening date<\/td>\nAugust 10, 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n
\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n